Suppr超能文献

碘甲状腺原氨酸5'-单脱碘酶(5'-MD)的酶结合抑制测定及其在大鼠肝脏5'-MD互补脱氧核糖核酸克隆分离中的应用。

Enzyme binding-inhibiting assay for iodothyronine 5'-monodeiodinase (5'-MD) and its application to isolation of complementary deoxyribonucleic acid clones for the 5'-MD in rat liver.

作者信息

Boado R J, Chopra I J, Flink I L, Campbell D A

机构信息

Department of Medicine, University of California School of Medicine, Los Angeles 90024.

出版信息

Endocrinology. 1988 Sep;123(3):1264-73. doi: 10.1210/endo-123-3-1264.

Abstract

To identify and/or quantify type I T4 5'-monodeiodinase (5'-MD) immunologically, polyclonal antibodies were produced by immunization of rabbits with solubilized microsomal proteins (SMP) from rat liver. Pilot studies showed that the antibody binds to, but does not neutralize, rat liver enzyme. We have employed the polyclonal antibody to develop a 5'-MD enzyme binding-inhibiting assay (MBIA). For this purpose, active, inactive, or synthetic 5'-MD was preincubated with rabbit antibody and removed by Staphylococcus aureus protein-A (Staph-A). The 5'-MD-binding sites that were left on the Staph-A-bound rabbit antibody were assayed by adding active 5'-MD in fresh liver SMP. After centrifugation of Staph-A, the unbound 5'-MD enzyme activity was measured in the supernatant using [125I]rT3 in the presence of dithiothreitol. Incubation with 3.2 +/- 0.9 micrograms (mean +/- SEM; n = 4) rat liver SMP inhibited the binding of active 5'-MD to protein-A-bound antibody by 50%. Based on doses with similar 50% binding inhibitory activity, liver SMP were 2.3 times more potent than liver microsomes and 19 times more potent than liver homogenate; liver nuclei and mitochondria showed little or no inhibition of the binding of 5'-MD to antibody. The relative 5'-MD content of liver, kidney, pituitary, placenta, and cerebral cortex based on relative potency in the MBIA approximated 100:25:8:3:3. The threshold of the MBIA approximated 0.9 micrograms liver SMP/tube. The coefficient of variation approximated 2% within an assay and 6% between assays. To obtain a cDNA clone for 5'-MD we used the SMP antibody to screen a rat liver lambda gt11 cDNA expression library. Of 16 positive (antibody-reactive) clones that were isolated, the fusion proteins from only 2 (no. 23 and 54) inhibited the binding of 5'-MD in rat liver SMP to protein-A-bound rabbit antibody in a dose-dependent manner. Western blot analysis showed that the molecular size of liver protein encoded by clones 23 and 54 approximates 31K. Sequence analysis showed that clone 23 insert is 804 basepairs long, contains a single long open-reading frame, and is identical to clone 54. Southern blot analysis showed that clones 23 and 54 did not cross-hybridize DNA from other SMP antibody-positive clones. Northern blot analysis using clone 23 insert cDNA as the probe showed a hybridization band corresponding to a mRNA approximating 2.8 kilobases.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

为了用免疫学方法鉴定和/或定量I型T4 5'-单碘酶(5'-MD),用大鼠肝脏的可溶性微粒体蛋白(SMP)免疫兔子制备了多克隆抗体。初步研究表明,该抗体能与大鼠肝脏酶结合,但不能使其失活。我们利用该多克隆抗体开发了一种5'-MD酶结合抑制测定法(MBIA)。为此,将活性、非活性或合成的5'-MD与兔抗体预孵育,并用金黄色葡萄球菌蛋白A(葡萄球菌A)去除。通过在新鲜肝脏SMP中加入活性5'-MD来检测结合在葡萄球菌A结合的兔抗体上剩余的5'-MD结合位点。葡萄球菌A离心后,在二硫苏糖醇存在下,使用[125I]rT3在上清液中测量未结合的5'-MD酶活性。与3.2±0.9微克(平均值±标准误;n = 4)大鼠肝脏SMP孵育可使活性5'-MD与蛋白A结合抗体的结合抑制50%。基于具有相似50%结合抑制活性的剂量,肝脏SMP的效力是肝脏微粒体的2.3倍,是肝脏匀浆的19倍;肝细胞核和线粒体对5'-MD与抗体结合的抑制作用很小或没有抑制作用。基于MBIA中的相对效力,肝脏、肾脏、垂体、胎盘和大脑皮层的相对5'-MD含量约为100:25:8:3:3。MBIA的阈值约为0.9微克肝脏SMP/管。同一次测定内的变异系数约为2%,不同次测定间的变异系数约为6%。为了获得5'-MD的cDNA克隆,我们用SMP抗体筛选大鼠肝脏λgt11 cDNA表达文库。在分离出的16个阳性(抗体反应性)克隆中,只有2个(编号23和54)的融合蛋白以剂量依赖方式抑制大鼠肝脏SMP中5'-MD与蛋白A结合的兔抗体的结合。蛋白质印迹分析表明,克隆23和54编码的肝脏蛋白的分子大小约为31K。序列分析表明,克隆23的插入片段长804个碱基对,包含一个单一的长开放阅读框,与克隆54相同。Southern印迹分析表明,克隆23和54与其他SMP抗体阳性克隆的DNA不发生交叉杂交。用克隆23插入片段cDNA作为探针进行Northern印迹分析,显示出一条与约2.8千碱基的mRNA相对应的杂交带。(摘要截断于400字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验